| Literature DB >> 26202520 |
Ada Rota1, Michela Corrò2, Ilenia Drigo3, Alessio Bortolami4, Stefan Börjesson5.
Abstract
BACKGROUND: Among the coagulase-positive, potentially pathogenic staphylococci, Staphylococcus pseudintermedius has been frequently isolated from bitches' milk. This organism colonizes the mammary gland or causes infection, while S. aureus has been only occasionally reported. The objective of this study was to investigate the occurrence and persistence of coagulase-positive staphylococci in the colostrum and milk of postpartum bitches, either treated or untreated with antimicrobials, and to assess the incidence, antibiotic resistance profile and genetic type of the methicillin-resistant strains. On postpartum D1, D7 and D15, drops of secretion were collected from the mammary glands of 27 postpartum bitches, nine of which were treated with antimicrobials. Coagulase-positive staphylococci were identified, antimicrobial susceptibility and the presence of mecA were tested and the genetic profile of methicillin-resistant strains was assessed.Entities:
Mesh:
Year: 2015 PMID: 26202520 PMCID: PMC4511979 DOI: 10.1186/s12917-015-0490-x
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Frequency of isolation of S. pseudintermedius at post-partum D1, D7 and D15 from bitches that received or did not receive antibiotic treatment in the first week post-partum
| D1 | D7 | D15 | |
|---|---|---|---|
| Treated bitches ( | 2/16 | 7/17 | 7/18 |
| Non treated bitches ( | 11/34(a) | 20/34(b) | 19/30(c) |
(a), (b), (c)indicate significant differences (P < 0.05)
Antimicrobial Susceptibility Test (Kirby Bauer method): results of methicillin-susceptible S. pseudintermedius (MSSP) and methicillin-resistant S. pseudintermedius (MRSP) strains
| Antimicrobials | S | I | R | |||
|---|---|---|---|---|---|---|
| MSSP (%) | MRSP (%) | MSSP (%) | MRSP (%) | MSSP (%) | MRSP (%) | |
| Penicillin | 0 | 0 | 0 | 0 | 100 | 100 |
| Ampicillin | 1.9 | 0 | 0 | 0 | 98.1 | 100 |
| Amoxicillin-clavulanic acid | 94.2 | 0 | 0 | 0 | 5.8 | 100 |
| Oxacillin | 100 | 0 | 0 | 0 | 0 | 100 |
| Cefalotin | 100 | 0 | 0 | 0 | 0 | 100 |
| Cefquinone | 96.2 | 0 | 3.8 | 0 | 0 | 100 |
| Spiramycin | 46.1 | 0 | 5.8 | 0 | 48.1 | 100 |
| Tilmicosin | 92.3 | 50 | 1.9 | 0 | 5.8 | 50 |
| Tylosin | 46.1 | 0 | 5.8 | 0 | 48.1 | 100 |
| Enrofloxacin | 100 | 35.7 | 0 | 7.1 | 0 | 57.1 |
| Clindamycin | 49.9 | 0 | 28.9 | 38.4 | 21.2 | 57.1 |
| Trimethoprim-sulfamethoxazole | 44.2 | 7.1 | 0 | 0 | 55.8 | 92.9 |
| Tetracycline | 42.3 | 7.1 | 0 | 0 | 57.7 | 92.9 |
| Trimethoprim-sulfamethoxazole | 67.3 | 35.7 | 0 | 0 | 32.7 | 64.3 |
| Tiamulin | 98.1 | 100 | 0 | 0 | 1.9 | 0 |
Sensitive (S), Intermediate (I), Resistant (R) were classified according to CLSI guidelines (CLSI 2013 a,b)
Fig. 1Typing of strains (N = 12). *denotes strains not subjected to MLST
Temporal sequence of isolation of the different genetic types of MRSP from colostrum (D1) and milk (D7, D15) of eight bitches housed in the same kennel and receiving or not receiving antibiotic treatment during 5–7 days postpartum (time interval July 2012-July 2013)
| Bitch | Ab | D1 | D7 | D15 | |||
|---|---|---|---|---|---|---|---|
| Right | Left | Right | Left | Right | Left | ||
| 1) | NO | X | NT-SCCmec IV- ST369 | X | |||
| 4) | YES | t02-SCCmec II/III-ST71 | |||||
| 2) | NO | t02-SCCmec II/III-ST71 | |||||
| 5) | aYES | NT-SCCmec IV- ST369 | |||||
| 6) | YES | t02-SCCmec II/III-ST71 | t02-SCCmec II/III-ST71 | t02-SCCmec II/III-ST71 | |||
| 7) | YES | t02-SCCmec II/III-ST71 | |||||
| 3) | bYES | NT-SCCmec IV- ST258 | NT-SCCmec IV- ST258 | NT-SCCmec IV- ST258 | |||
| 8) | YES | NT-SCCmec IV- ST258 | |||||
Ab antibiotic administration
abitch showing mastitis
bbitch showing vulvar abscess and dermatitis